NVAX Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Novavax, Inc.

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

19 days ago - By: Benzinga - Mentions: AZN GSK MRK PFE ...

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

19 days ago - By: Stocktwits - Mentions: IWMW ISCB

Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity

a month ago - By: Novavax, Inc.

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

a month ago - By: Zacks Investment Research

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider

a month ago - By: Novavax, Inc.

Novavax Announces Progress on Sanofi Agreement

a month ago - By: Stocktwits - Mentions: SNY

Novavax Amends Deal With Sanofi, Broadens Partnership

a month ago - By: Benzinga - Mentions: DVAX GSK MRK PFE ...

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

a month ago - By: Investor's Business Daily - Mentions: PFE MRNA BNTX

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids

2 months ago - By: Zacks Investment Research

Here's Why Novavax (NVAX) Fell More Than Broader Market

2 months ago - By: Stocktwits - Mentions: IWMW VTWG

Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda

a month ago - By: Investor's Business Daily - Mentions: PFE BNTX MRNA

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut

2 months ago - By: Zacks Investment Research - Mentions: PFE MRNA BNTX

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

2 months ago - By: Zacks Investment Research

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

2 months ago - By: Investor's Business Daily - Mentions: PFE MRNA BNTX

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?

2 months ago - By: Novavax, Inc.

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

2 months ago - By: Zacks Investment Research - Mentions: PFE MRNA BYD SCVL

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

2 months ago - By: Yahoo Finance

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

2 months ago - By: Zacks Investment Research - Mentions: PFE MRNA

FDA Approves Updated COVID-19 Vaccines but With Restrictions

2 months ago - By: Zacks Investment Research

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term

2 months ago - By: Yahoo Finance

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults

2 months ago - By: Novavax, Inc.

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

2 months ago - By: Investor's Business Daily - Mentions: PFE BNTX MRNA

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.

2 months ago - By: Stocktwits - Mentions: MRNA PFE

Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups

2 months ago - By: Zacks Investment Research

NOVAVAX INC (NVAX) Stock News

NVAX Latest News, Press Relases and Analysis

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider

Novavax Announces Progress on Sanofi Agreement

Novavax Amends Deal With Sanofi, Broadens Partnership

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids

Here's Why Novavax (NVAX) Fell More Than Broader Market

Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

FDA Approves Updated COVID-19 Vaccines but With Restrictions

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.

Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It